Abstract P6-01-46: Independent Validation of the HER2DX Genomic Test in HER2-positive Breast Cancer Treated with Neoadjuvant Docetaxel, Carboplatin, Trastuzumab +/- Pertuzumab (TCH/TCHP): a Correlative Analysis from a Multicenter Academic Study

Cancer research(2023)

引用 0|浏览40
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要